Key result
Insulin-induced hypoglycemia in diabetic mice induced vascular smooth muscle cell fibrosis, endothelial cell PANoptosis, and macrophage inflammatory polarization.
Why the study?
Hypoglycemia leads to cardiovascular events via endothelial dysfunction, but a comprehensive understanding of lineage-specific variations in pathological vascular changes is needed.
This study elucidates the mechanisms of hypoglycemia-induced macroangiopathy in diabetes, highlighting endothelial PANoptosis and VSMC fibrosis, and identifies Angptl4 as a potential therapeutic target.
Animal findings do not inform clinical practice; leaves open Angptl4 targeting for hypoglycemia-related vascular fibrosis in diabetes.
Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia-triggered cytokine release and inflammatory programmed cell death. A comprehensive understanding of lineage-specific variations in pathological vascular changes is essential to mitigate cardiovascular events and ensure therapeutic efficacy. Herein, unbiased clustering analyses and single-nucleus RNA sequencing are performed on cells of the thoracic aorta in db/db and insulin-induced hypoglycemic db/db mice. Comparative analyses show changes in lineage-specific genes, subpopulation composition, intercellular communication, and molecular biology in hypoglycemic diabetic mice. The analyses also revealed the changes of different cells, particularly endothelial cell PANoptosis, macrophage inflammatory polarization, and vascular smooth muscle cell (VSMC) fibrosis. Pseudo-time sequencing, differential expression, and regulation network analyses revealed the association of potential hub genes Klf2, ETS2, Elavl1, C3, and Nr4a1 with the mentioned pathological processes. It is demonstrated that hypoglycemia induces VSMC fibrosis in vivo, whereas Angptl4 knockdown can attenuate VSMC fibrosis in vitro. These findings demonstrate the hypoglycemic macroangiopathy mechanism and provide important references for future disease intervention and treatment.
No takes yet. Share an insight, caveat, or question.
Zuo et al. (2025) studied Diabetic macrovascular endothelial dysfunction and hypoglycemia. Insulin-induced hypoglycemia vs. db/db mice (diabetic control) was evaluated on Lineage-specific variations in pathological vascular changes (endothelial cell PANoptosis, macrophage polarization, and VSMC fibrosis). Insulin-induced hypoglycemia in diabetic mice induced vascular smooth muscle cell fibrosis, endothelial cell PANoptosis, and macrophage inflammatory polarization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: